Steroid-Free Regimen Post-Pediatric Renal Transplant SafeDoctors LoungeParticipants were randomly allocated to steroid-free (SF) or steroid-based (SB) immunosuppression, together with tacrolimus, mycophenolate, and standard or extended-dose daclizumab …
DetikcomBasilimixab – detikHealth : Tetap Sehat DimanapunDetikcomKetika seorang pasien menerima transplantasi ginjal, sel-sel darah putih tubuh akan mencoba untuk menolak ginjal tersebut. Basiliximab bekerja dengan mencegah sel-sel darah putih ini meno…
Cancer drug price droppedBizcommunity.comThe Department of Health has persuaded pharmaceutical company Roche to halve the price of its cancer drug rituximab, opening the way for the government to provide it to more patients. The drug belongs to an expe…
An efficient approach for rheumatoid arthritis managementPhilippine StarIn March 2011, Ribargoso started Santos on rituximab infusions. … Rituximab is a unique therapy for rheumatoid arthritis, specifically targeting the B cell — a …
Anti-Thymocyte Globulin Prior To Transplantation May Improve …The MDS BeaconSpecifically, patients treated with anti-thymocyte globulin (ATG) during preparative treatment experienced significantly fewer cases of acute graft-versus-host …
Post (subscription)'Cancer drug price dropped'Post (subscription)The department's deputy director general for regulation Anban Pillay said the drug rituximab, dubbed MabThera by Roche, had previously been too expensive for the state to buy …
Independent Online'Cancer drug price dropped'Independent OnlineThe department's deputy director general for regulation Anban Pillay said the drug rituximab, dubbed MabThera by Roche, had previously been too expensive …State patients to be…
Cell Therapeutics Readies Commercial Launch of Pixuvri® in EU; Re-Alignment …Business Review India (press release)CTI is currently accruing patients into a Phase III trial comparing pixantrone and rituximab with gemcitabine and rituxan in the settin…
Cell Therapeutics Readies Commercial Launch of Pixuvri® in EU …MarketWatch (press release)CTI is currently accruing patients into a Phase III trial comparing pixantrone and rituximab with gemcitabine and rituxan in the setting of aggressive B-cell ….
State patients to benefit as Roche is persuaded to cut price of cancer …Business DayThe Department of Health has persuaded pharmaceutical company Roche to halve the price of its cancer drug rituximab, opening the way for the government to …and more…